DaVita (DVA) delivered strong Q1 FY2026 results with revenue up 6.0% YoY to $3.42B and net income surging 21.2% to $197.5M, driven by improved operating leverage and significantly higher operating cash flow of $320.8M.
Key risk: Deeply Negative Stockholders' Equity
DaVita's stockholders' equity deteriorated sharply to -$755.5M from -$267.1M a year ago, a decline of 182.9% YoY. This negative equity position, driven by accumulated share repurchases and debt-financed operations, could limit financial flexibility and raise concerns among lenders or counterparties.
Other Health Care Services companies